GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. | Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | Merck Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals. | Johnson & Johnson Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. | Roche Roche Holding is a biotech company that provides in-vitro diagnostics and supplies solutions across various disease areas. | AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | Takeda Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | Eli Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. | ||
Founding Date | Founding Date 2000 | Founding Date 1849 | Founding Date 1891 | Founding Date 1886 | Founding Date 1896 | Founding Date 1999 | Founding Date 1781 | Founding Date 1863 | Founding Date 1876 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||||
Locations | Locations Brentford, GB HQ Boumerdes, DZ San Fernando, AR Abbotsford, AU Boronia, AU Ermington, AU Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Bentley, AU Footscray, AU Mulgrave, AU Sydney, AU see more | Locations Rahway, US HQ Hydra, DZ Munro, AR Macquarie Park, AU Krems An Der Donau, AT Wien, AT Bruxelles, BE see more | Locations New Brunswick, US HQ Buenos Aires, AR Sydney, AU Ultimo, AU Wien, AT Minsk, BY Beerse, BE see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more | |||
Employees | Employees 70,212 | Employees 83,0005% increase | Employees 72,0007% increase | Employees 131,90014% decrease | Employees 103,605 | Employees 89,900 | Employees 49,281 | Employees 94,2454% decrease | Employees 39,00011% increase |
Valuation ($) | Valuation ($) 862.5 m | Valuation ($) 163.9 b | Valuation ($) 294.7 b | Valuation ($) 396.3 b | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) 43.7 b | Valuation ($) 27.1 b | Valuation ($) 903.4 b |
Financial | |||||||||
Revenue (est.) | Revenue (est.) £30.3b (FY, 2023) | Revenue (est.) $58.5b (FY, 2023) | Revenue (est.) $60.1b (FY, 2023) | Revenue (est.) $85.2b (FY, 2023) | Revenue (est.) CHF58.7b (FY, 2023) | Revenue (est.) $45.8b (FY, 2023) | Revenue (est.) ¥4.3t (FY, 2024) | Revenue (est.) €47.6b (FY, 2023) | Revenue (est.) $34.1b (FY, 2023) |
Cost of goods | Cost of goods £5.8b (FY, 2023) | Cost of goods $25b (FY, 2023) | Cost of goods $16.1b (FY, 2023) | Cost of goods $26.6b (FY, 2023) | Cost of goods CHF12.4b (FY, 2023) | Cost of goods $7.2b (FY, 2023) | Cost of goods ¥698.7b (FY, 2024) | Cost of goods €7b (FY, 2023) | Cost of goods $7.1b (FY, 2023) |
Gross profit | Gross profit £25.7b (FY, 2023) | Gross profit $33.5b (FY, 2023) | Gross profit $44b (FY, 2023) | Gross profit $58.6b (FY, 2023) | Gross profit CHF48.5b (FY, 2023) | Gross profit $39.8b (FY, 2023) | Gross profit ¥3.6t (FY, 2024) | Gross profit €42.1b (FY, 2023) | Gross profit $27b (FY, 2023) |
Net income | Net income £5.3b (FY, 2023) | Net income $2.2b (FY, 2023) | Net income $377m (FY, 2023) | Net income $35.2b (FY, 2023) | Net income CHF12.4b (FY, 2023) | Net income $6b (FY, 2023) | Net income ¥144.2b (FY, 2024) | Net income (€2.9b) (FY, 2023) | Net income $5.2b (FY, 2023) |
Operating ⚠ | |||||||||
Countries | Countries 92 (FY, 2021) | Countries 125 (FY, 2021) | Countries N/A | Countries N/A | Countries N/A | Countries 130 (FY, 2021) | Countries N/A | Countries 83 (FY, 2021) | Countries 120 (FY, 2021) |
Phase I Trials Products | Phase I Trials Products 16 (FY, 2021) | Phase I Trials Products 27 (FY, 2021) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 27 (FY, 2019) |
Phase II Trials Products | Phase II Trials Products 6 (FY, 2021) | Phase II Trials Products 25 (FY, 2021) | Phase II Trials Products 85 (FY, 2022) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 8 (FY, 2021) |
Phase III Trials Products | Phase III Trials Products 11 (FY, 2021) | Phase III Trials Products 27 (FY, 2021) | Phase III Trials Products 32 (FY, 2022) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 10 (FY, 2021) |
Suppliers | Suppliers 37.5 k (FY, 2021) | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers 93.8 k (FY, 2021) | Suppliers N/A |
Funding | |||||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7.8b | Total funding raised $ 1b | Total funding raised $ 57.8m | Total funding raised $ 3.5b | Total funding raised N/A |